DossierENTITY

$400 billion megadeal

Coverage of $400 billion megadeal in the Nexus archive.

Earliest in view: Aug 2 · 21:40 UTCMost recent: Aug 2 · 21:40 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSAug 2 · 21:40 UTCNY POST
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
AstraZeneca is in talks with Bristol Myers Squibb to finalize a $400 billion megadeal, which would create one of the world's largest pharmaceutical groups with a combined value of nearly $400 billion.